Company / Revenue per Share
LivaNova Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$25.54
FY2025
5-year range
$17.54 / $25.54
FY2021-FY2025
Trend
+9.9%
vs FY2024
Sector context
#72 of 153
Health Care
What the data says
At $25.54, LivaNova's revenue per share ranks #72 of 153 in the Health Care sector. Revenue per Share has increased for 3 consecutive years, from $17.54 in FY2022 to $25.54 in FY2025.
Based on SEC 10-K filings.
25.54 in FY2025 with a 5-year CAGR of +5.8%.
Improved from $21.54 to $25.54 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +13.3%
- 5-Year CAGR
- +5.8%
- 10-Year CAGR
- -
Sector benchmark
#72 of 153 in Health CareTop 47% of 153This company $25.54 Sector average $123.62
▼
-79.3% below sector average
Key checks
Key Insights
- LivaNova's revenue per share has grown for 3 consecutive years.
- In FY2025, revenue per share increased 9.9% year-over-year.
- Ranks #72 out of 153 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $25.54 | +9.9% |
| FY2024 | $23.25 | +7.9% |
| FY2023 | $21.54 | +22.8% |
| FY2022 | $17.54 | -21.3% |
| FY2021 | $22.28 | +15.5% |
| FY2020 | $19.29 | -14.3% |
| FY2019 | $22.49 | -1.9% |
| FY2018 | $22.92 | +108667.2% |
| FY2017 | $0.02 | -99.9% |
| FY2016 | $37.12 | +234.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026